Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,954 | 122,715 | 122,470 | 114,248 | 46,928 |
| Marketable Securities | 98,417 | 67,893 | 59,731 | 209,444 | 186,452 |
| Receivables | 21,266 | 12,660 | 3,985 | N/A | N/A |
| Inventories | 31,122 | 21,599 | 3,675 | N/A | N/A |
| Other current assets | 0 | 7,656 | 0 | 0 | 0 |
| TOTAL | $276,297 | $243,060 | $196,446 | $333,249 | $241,627 |
| Non-Current Assets | |||||
| PPE Net | 734 | 1,658 | 2,834 | 4,051 | 6,398 |
| Intangibles | 17,250 | 18,250 | 19,250 | 0 | 0 |
| Other Non-Current Assets | 232,041 | 196,704 | 14,270 | 12,164 | 6,509 |
| TOTAL | $250,025 | $216,612 | $36,354 | $16,215 | $12,907 |
| Total Assets | $526,322 | $459,672 | $232,800 | $349,464 | $254,534 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,246 | 7,899 | 1,868 | 503 | 5,693 |
| Accrued Expenses | 44,667 | 30,112 | 38,031 | 29,199 | 20,415 |
| Other current liabilities | 8,193 | 5,754 | 1,544 | 37 | 25 |
| TOTAL | $63,666 | $47,066 | $44,824 | $31,846 | $27,830 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 307 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 11,863 | 4,457 | 2,939 | 5,683 | 1,281 |
| TOTAL | $23,817 | $16,457 | $2,939 | $5,683 | $1,281 |
| Total Liabilities | $87,483 | $63,523 | $47,763 | $37,529 | $29,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,615 | 69,753 | 69,104 | 68,232 | 55,547 |
| Common Shares | 20 | 19 | 18 | 18 | 15 |
| Retained earnings | -477,950 | -492,034 | -675,397 | -517,473 | -356,092 |
| Other shareholders' equity | 6 | 44 | -66 | -34 | 33 |
| TOTAL | $438,839 | $396,149 | $185,037 | $311,935 | $225,423 |
| Total Liabilities And Equity | $526,322 | $459,672 | $232,800 | $349,464 | $254,534 |